Li, F., Leroux, C., Craigo, J.K., Cook, S.J., Issel, C.J.,
and Montelaro, R.C. 2000. The S2 gene of equine infectious
anemia virus is a highly conserved determinant of viral
replication and virulence properties in experimentally
infected ponies. J. Virol. 74:573-579.
Hammond, S.A., Li, F., McKeon, B.M., Sr., Cook, S.J.,
Issel, C.J., and Montelaro, R.C. 2000. Immune responses
and viral replication in long-term inapparent carrier ponies
inoculated with equine infectious anemia virus. J. Virology
74:5968-5981.
Cook, S.J., Cook, R.F., Montelaro, R.C., and Issel, C.J.
2001. Differential responses of Equus caballus and Equus
asinus to infection with 2 pathogenic strains of equine
infectious anemia virus. Vet Micro. 79:93-109.
Leroux, C., Craigo, J.K., Issel, C.J., and Montelaro,
R.C. 2001. Equine infectious anemia virus genomic evolution
in progressor and non-progressor ponies. J. Virol. 75:4570-4583.
Issel, C.J., Sinclear, J.N., Bolin, P.S., Cook, S.J.,
Anderson, G., Marshall, M., Rogers, L.E., Mathis, J., and
Lekas, J. 2000. Investigations on equine infectious anemia
in equids from the Uintah Basin in Utah, 1999-2000. US
An Health Assn. Proc. 104:372-382.
Craigo, J.K., Leroux, C., Howe, L., Steckbeck, J.D., Cook,
S.J., Issel, C.J., and Montelaro, R.C. 2002. Transient
immune suppression of inapparent carrier ponies infected
with neutralization-resistant EIAV redirects antibody responses
and lowers steady state viral replication. J. Gen Virol
83:1353-1359.
Zhou, W., Cook, R.F., Cook, S.J., Hammond, S.A., Rushlow,
K., Ghabrial, N.N., Berger, S.L., Montelaro, R.C., and
Issel, C.J. 2002. Multiple RNA splicing and the presence
of cryptic RNA splice donor and acceptor sites may contribute
to low expression levels and poor immunogenicity of potential
DNA vaccines containing the env gene of equine infectious
anemia virus (EIAV). Vet Micro 88/2:127-151.
Cook, R.F., Cook, S.J., Li, F., Montelaro, R.C., and Issel,
C.J. 2002. Development of a multiplex real-time reverse
transcriptase-polymerase chain reaction for equine infectious
anemia virus (EIAV). J Virol Meth 105:171-179.
Howe, L., Leroux, C., Issel, C.J., and Montelaro, R.C.
2002. Equine infectious anemia virus envelope evolution in
vivo during persistent infection progressively increases
resistance to in vitro serum antibody neutralization
as a dominant phenotype. J. Virol. 76(21):10588-10597.
Li, F., Craigo, J.K., Howe, L., Steckbeck, J.D., Cook,
S., Issel, C., and Montelaro, R.C. 2003. A live attenuated
EIAV proviral vaccine with a modified S2 gene provides
protection from detectable infection by intravenous virulent
virus challenge of experimentally inoculated horses. J.
Virology 77(13):7244-7253.
Reis, J.K.P., Craigo, J.K., Cook, S.J., Issel, C.J., and
Montelaro, R.C. 2003. Characterization of EIAV LTR variability
and compartmentalization in various reservoir tissues of
long term inapparent carrier ponies. Virology 311:169-180.
Cook, R.F., Cook, S.J., Berger, S.L., Leroux, C., Ghabrial,
N.N., Gantz, M., Bolin, P.S., Mousel, M.R., Montelaro,
R.C. and Issel, C.J. 2003. Enhancement of equine infectious
anemia virus virulence by identification and removal of
suboptimal nucleotides. Virology 313:588-603.
Jin, S., Issel, C.J., and Montelaro, R.C. 2004. Differential
serological diagnosis of equine infectious anemia virus
infected and vaccinated horses using recombinant S2 protein.
Clin. and Diag. Lab. Imm. 11(6):1120-1129.
Issel, C.J., and Cook, S.J. 2004. Equine infectious anemia
testing and control of EIA: how much is enough? USAnHealthAssn
Proc 108:316-327.
Howe, L., Craigo, J., Issel, C.J., and Montelaro, R.C.
2005. Development of serum neutralizing antibodies to a
neutralization resistant EIAV?PND envelope variant after
immune suppression of experimentally infected ponies results
from changes in host antibodies directed to gp90 V3 and
V4 domains. J. Gen. Virol. 86:139-149.
Craigo, J.K., Steckbeck, J.D., Durkin, S., Howe, L., Cook,
S.J., Issel, C. and Montelaro, R.C. 2005. Discerning an
effective balance between equine infectious anemia virus
attenuation and vaccine efficacy. J. Virol. 79(5):2666-2677.
Issel, C.J. 2005. Equine infectious anemia (EIA): 25 years
and $600,000,000 later. Equine Disease Quarterly. Newsletter:
14(1).
Craigo, J.K., Sturgeon, T., Cook, S.J., Issel, C.J., Leroux,
C. and Montelaro, R.C. 2005. Apparent elimination of EIAV
ancestral species in a long-term inapparent carrier. Virology.(October
issue)
Cook, R.F., Cook, S.J., Bolin, P.S., Howe, L.J., Montelaro,
R.C. and Issel, C.J. 2005. Genetic immunization with codon-optimized
equine infectious anemia virus (EIAV) surface unit (SU)
envelope protein gene sequences stimulates immune responses
in ponies. Vet Microbiol. 108(1-2):23-37.
Craigo, J.K., Sturgeon, T., Cook, S.J., Issel, C.J., Leroux, C. and Montelaro, R.C. 2006. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Virology 344:340-353.
Craigo, J.K., Durkin S., Sturgeon TJ, Tagmyer, T., Cook SJ, Issel CJ, and Montelaro RC. 2006. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine 2006:834-845.
Tagmyer, T., Craigo, J.K., Cook, S.J., Issel, C.J. and Montelaro, R.C. 2007. Characterization of broadly reactive T-helper and CTL epitopes in the envelope proteins of equine infectious anemia virus. J. Gen Virology 88:1324-1336.
Issel, C.J., Cordes, T.R., and Halstead, S. 2007. Control of EIA should take some new directions. Article#8787 on TheHorse.com (accessed 2/28/2007 at http://www.thehorse.com/ViewArticle.aspx?ID=8787).
Issel, C.J. and Anderson, G. 2007. The stigma of EIA is misplaced. Article#9038 on TheHorse.com (accessed 3/2/2007 at http://www.thehorse.com/ViewArticle.aspx?ID=9038).
Craigo JK, Zhang B, Barnes S, Tagmyer TL, Cook SJ, Issel CJ, Montelaro RC. 2007. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proc Nat Acad Sci USA 104: 15105-15110.
